Impact of left atrial appendage flow velocity on thrombus resolution and clinical outcomes in patients with atrial fibrillation and silent left atrial thrombi: insights from the LAT study
Open Access
- 1 May 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 26 (5)
Abstract
Aims: Blood stasis is crucial in developing left atrial (LA) thrombi. LA appendage peak flow velocity (LAAFV) is a quantitative parameter for estimating thromboembolic risk. However, its impact on LA thrombus resolution and clinical outcomes remains unclear. Methods and results: The LAT study was a multicentre observational study investigating patients with atrial fibrillation (AF) and silent LA thrombi detected by transoesophageal echocardiography (TEE). Among 17 436 TEE procedures for patients with AF, 297 patients (1.7%) had silent LA thrombi. Excluding patients without follow-up examinations, we enrolled 169 whose baseline LAAFV was available. Oral anticoagulation use increased from 85.7% at baseline to 97.0% at the final follow-up (P < 0.001). During 1 year, LA thrombus resolution was confirmed in 130 (76.9%) patients within 76 (34–138) days. Conversely, 26 had residual LA thrombi, 8 had thromboembolisms, and 5 required surgical removal. These patients with failed thrombus resolution had lower baseline LAAFV than those with successful resolution (18.0 [15.8–22.0] vs. 22.2 [17.0–35.0], P = 0.003). Despite limited predictive power (area under the curve, 0.659; P = 0.001), LAAFV ≤ 20.0 cm/s (best cut-off) significantly predicted failed LA thrombus resolution, even after adjusting for potential confounders (odds ratio, 2.72; 95% confidence interval, 1.22–6.09; P = 0.015). The incidence of adverse outcomes including ischaemic stroke/systemic embolism, major bleeding, or all-cause death was significantly higher in patients with reduced LAAFV than in those with preserved LAAFV (28.4% vs. 11.6%, log-rank P = 0.005). Conclusion: Failed LA thrombus resolution was not rare in patients with AF and silent LA thrombi. Reduced LAAFV was associated with failed LA thrombus resolution and adverse clinical outcomes.Keywords
Funding Information
- Japan Agency for Medical Research and Development (JP18ek0210056)
This publication has 37 references indexed in Scilit:
- Impact of Increased Orifice Size and Decreased Flow Velocity of Left Atrial Appendage on Stroke in Nonvalvular Atrial FibrillationThe American Journal of Cardiology, 2014
- Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisitedThe Lancet, 2009
- Left Atrial Appendage Flow Velocity as a Quantitative Surrogate Parameter for Thromboembolic Risk: Determinants and Relationship to Spontaneous Echocontrast and Thrombus Formation–A Transesophageal Echocardiographic Study in 500 Patients with Cerebral IschemiaJournal of the American Society of Echocardiography, 2005
- Left atrial appendage flow velocities in subjects with normal left ventricular functionThe American Journal of Cardiology, 2000
- Efficacy of anticoagulation in resolving left atrial and left atrial appendage thrombi: A transesophageal echocardiographic studyAmerican Heart Journal, 2000
- Pathophysiologic Correlates of Thromboembolism in Nonvalvular Atrial Fibrillation: I. Reduced Flow Velocity in the Left Atrial Appendage (The Stroke Prevention in Atrial Fibrillation [SPAF-III] Study)Journal of the American Society of Echocardiography, 1999
- Transesophageal Echocardiographic Correlates of Clinical Risk of Thromboembolism in Nonvalvular Atrial FibrillationJACC, 1998
- A Method to Determine the Optimal Intensity of Oral Anticoagulant TherapyThrombosis and Haemostasis, 1993
- Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.Stroke, 1991
- Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III.Stroke, 1990